Proteasome inhibition in hypertrophied myocardium.
Friehs
Ingeborg
I
D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D006332:Cardiomegaly / Q000150:complications / Q000188:drug therapy* / Q000201:enzymology / Q000503:physiopathology; D003094:Collagen / Q000378:metabolism; D004195:Disease Models, Animal; D006333:Heart Failure / Q000201:enzymology / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control; D006801:Humans; D009206:Myocardium / Q000201:enzymology* / Q000473:pathology; D016328:NF-kappa B / Q000378:metabolism; D009842:Oligopeptides / Q000494:pharmacology; D011480:Protease Inhibitors / Q000494:pharmacology*; D046988:Proteasome Endopeptidase Complex / Q000378:metabolism; D061988:Proteasome Inhibitors; D016277:Ventricular Function, Left / Q000187:drug effects; D020257:Ventricular Remodeling / Q000187:drug effects*
D016328:NF-kappa B; D009842:Oligopeptides; D011480:Protease Inhibitors; D061988:Proteasome Inhibitors; D003094:Collagen; D046988:Proteasome Endopeptidase Complex; C078846:epoxomicin